China Dasheng Biotechnology Company (CDBT)

CDBT Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2008	FY 2007	FY 2006
Period Ending	Mar 31, 2025	Jun 30, 2008	Jun 30, 2007	Jun 30, 2006
Market Capitalization	2	59	-	-
Enterprise Value	25	57	-	-
Last Close Price	0.06	1.95	-	-
PE Ratio	0.28	12.61	-	-
PS Ratio	0.08	3.59	-	-
PB Ratio	0.09	3.39	-	-
P/TBV Ratio	1.69	4.13	-	-
P/FCF Ratio	0.29	14.38	-	-
P/OCF Ratio	3.05	14.28	-	-
EV/Sales Ratio	1.21	3.51	-	-
EV/EBITDA Ratio	3.28	10.02	-	-
EV/EBIT Ratio	3.60	11.25	-	-
EV/FCF Ratio	3.04	14.04	-	-
Debt / Equity Ratio	0.00	-	0.11	-
Debt / EBITDA Ratio	0.00	-	0.34	-
Debt / FCF Ratio	0.00	-	3.31	-
Asset Turnover	0.95	0.91	-	-
Inventory Turnover	18.30	9.49	-	-
Quick Ratio	6.36	3.15	2.37	-
Current Ratio	6.63	5.52	3.67	-
Return on Equity (ROE)	39.15%	37.44%	-	-
Return on Assets (ROA)	19.87%	17.80%	-	-
Return on Capital (ROIC)	23.49%	22.00%	-	-
Return on Capital Employed (ROCE)	29.20%	27.10%	21.30%	-
Earnings Yield	264.98%	7.93%	-	-
FCF Yield	344.77%	6.95%	-	-
Buyback Yield / Dilution	6.48%	6.48%	-	-

Updated May 14, 2009. Source: S&P Global Market Intelligence. Standard template. Financial Sources.